Pathophysioloy and treatment of painful diabetic neuropathy

Mitra Tavakoli, Moaz Mojaddidi, Hassan Fadavi, Rayaz Malik

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Diabetes is the most common cause of peripheral neuropathy, and painful diabetic neuropathy (PDN) affects approximately 30% of diabetic patients with neuropathy. It is extremely distressing for the patient and poses significant management difficulties because no treatment provides total relief, and side effects of therapy are a major limiting factor for titrating therapy. Understanding the pathogenesis of diabetic neuropathy may lead to the development of new treatments to prevent nerve damage, and a better understanding of the mechanisms that modulate pain may lead to more effective relief of painful symptoms. We provide an update on the pathogenesis, diagnosis, and treatment of PDN.

Original languageEnglish
Pages (from-to)192-197
Number of pages6
JournalCurrent Pain and Headache Reports
Volume12
Issue number3
DOIs
Publication statusPublished - Jun 2008
Externally publishedYes

Fingerprint

Diabetic Neuropathies
Therapeutics
Peripheral Nervous System Diseases
Pain

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Pathophysioloy and treatment of painful diabetic neuropathy. / Tavakoli, Mitra; Mojaddidi, Moaz; Fadavi, Hassan; Malik, Rayaz.

In: Current Pain and Headache Reports, Vol. 12, No. 3, 06.2008, p. 192-197.

Research output: Contribution to journalReview article

Tavakoli, Mitra ; Mojaddidi, Moaz ; Fadavi, Hassan ; Malik, Rayaz. / Pathophysioloy and treatment of painful diabetic neuropathy. In: Current Pain and Headache Reports. 2008 ; Vol. 12, No. 3. pp. 192-197.
@article{8157d267f0ed4566ab7cf5c495754e53,
title = "Pathophysioloy and treatment of painful diabetic neuropathy",
abstract = "Diabetes is the most common cause of peripheral neuropathy, and painful diabetic neuropathy (PDN) affects approximately 30{\%} of diabetic patients with neuropathy. It is extremely distressing for the patient and poses significant management difficulties because no treatment provides total relief, and side effects of therapy are a major limiting factor for titrating therapy. Understanding the pathogenesis of diabetic neuropathy may lead to the development of new treatments to prevent nerve damage, and a better understanding of the mechanisms that modulate pain may lead to more effective relief of painful symptoms. We provide an update on the pathogenesis, diagnosis, and treatment of PDN.",
author = "Mitra Tavakoli and Moaz Mojaddidi and Hassan Fadavi and Rayaz Malik",
year = "2008",
month = "6",
doi = "10.1007/s11916-008-0034-1",
language = "English",
volume = "12",
pages = "192--197",
journal = "Current Pain and Headache Reports",
issn = "1531-3433",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - Pathophysioloy and treatment of painful diabetic neuropathy

AU - Tavakoli, Mitra

AU - Mojaddidi, Moaz

AU - Fadavi, Hassan

AU - Malik, Rayaz

PY - 2008/6

Y1 - 2008/6

N2 - Diabetes is the most common cause of peripheral neuropathy, and painful diabetic neuropathy (PDN) affects approximately 30% of diabetic patients with neuropathy. It is extremely distressing for the patient and poses significant management difficulties because no treatment provides total relief, and side effects of therapy are a major limiting factor for titrating therapy. Understanding the pathogenesis of diabetic neuropathy may lead to the development of new treatments to prevent nerve damage, and a better understanding of the mechanisms that modulate pain may lead to more effective relief of painful symptoms. We provide an update on the pathogenesis, diagnosis, and treatment of PDN.

AB - Diabetes is the most common cause of peripheral neuropathy, and painful diabetic neuropathy (PDN) affects approximately 30% of diabetic patients with neuropathy. It is extremely distressing for the patient and poses significant management difficulties because no treatment provides total relief, and side effects of therapy are a major limiting factor for titrating therapy. Understanding the pathogenesis of diabetic neuropathy may lead to the development of new treatments to prevent nerve damage, and a better understanding of the mechanisms that modulate pain may lead to more effective relief of painful symptoms. We provide an update on the pathogenesis, diagnosis, and treatment of PDN.

UR - http://www.scopus.com/inward/record.url?scp=48749090532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749090532&partnerID=8YFLogxK

U2 - 10.1007/s11916-008-0034-1

DO - 10.1007/s11916-008-0034-1

M3 - Review article

VL - 12

SP - 192

EP - 197

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 3

ER -